Teva Pharmaceuticals generic medicine

Teva Pharmaceutical Industries Ltd. is a global leader in the pharmaceutical industry, specializing in generic and innovative medicines. Founded in Jerusalem in 1901 by Chaim Salomon, Moshe Levin, and Yitschak Elstein, the company began as a small wholesale drug business. Over the decades, it grew through strategic acquisitions and internal development to become one of the largest generic drug manufacturers in the world.

Today, Teva operates a vast global manufacturing network with facilities located in Israel, the United States, Europe, and Asia. While its corporate headquarters and significant research and development operations remain in Tel Aviv, Israel, its products are manufactured in multiple locations to serve global markets according to regional regulatory standards.

Teva is a publicly-owned company traded on the New York Stock Exchange and the Tel Aviv Stock Exchange. It remains an independent entity, making it the ultimate owner of its brand and various specialized subsidiaries worldwide. The company continues to focus on its 'Pivot to Growth' strategy, emphasizing both its strong generic portfolio and its development of innovative specialty medicines in areas such as neuroscience and immunology.